Gage B - Search Results

1

Quality of anticoagulation with warfarin in rural Chhattisgarh, India.

Chebrolu P, Patil S, Laux TS, Al-Hammadi N, Jain Y, Gage B. Chebrolu P, et al. Among authors: gage b. Indian J Med Res. 2020 Sep;152(3):303-307. doi: 10.4103/ijmr.IJMR_1201_18. Indian J Med Res. 2020. PMID: 33107491 Free PMC article.

2

Management and dosing of warfarin therapy.

Gage BF, Fihn SD, White RH. Gage BF, et al. Am J Med. 2000 Oct 15;109(6):481-8. doi: 10.1016/s0002-9343(00)00545-3. Am J Med. 2000. PMID: 11042238 Review.

3

Patient and physician satisfaction with a telephone-based anticoagulation service.

Waterman AD, Banet G, Milligan PE, Frazier A, Verzino E, Walton B, Gage BF. Waterman AD, et al. Among authors: gage bf. J Gen Intern Med. 2001 Jul;16(7):460-3. doi: 10.1046/j.1525-1497.2001.016007460.x. J Gen Intern Med. 2001. PMID: 11520383 Free PMC article. Clinical Trial.

4

Substitution of generic warfarin for Coumadin in an HMO setting.

Milligan PE, Banet GA, Waterman AD, Gatchel SK, Gage BF. Milligan PE, et al. Ann Pharmacother. 2002 May;36(5):764-8. doi: 10.1345/aph.1A327. Ann Pharmacother. 2002. PMID: 11978149 Clinical Trial.

5

Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.

Banet GA, Waterman AD, Milligan PE, Gatchel SK, Gage BF. Banet GA, et al. Chest. 2003 Feb;123(2):499-503. doi: 10.1378/chest.123.2.499. Chest. 2003. PMID: 12576372 Clinical Trial.

6

Cost-savings analysis of using a portable coagulometer for monitoring homebound elderly patients taking warfarin.

Cheung DS, Heizer D, Wilson J, Gage BF. Cheung DS, et al. Am J Geriatr Cardiol. 2003 Sep-Oct;12(5):283-7. doi: 10.1111/j.1076-7460.2003.02053.x. Am J Geriatr Cardiol. 2003. PMID: 12963852

7

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL. Gage BF, et al. Thromb Haemost. 2004 Jan;91(1):87-94. doi: 10.1160/TH03-06-0379. Thromb Haemost. 2004. PMID: 14691573

8

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.

Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, Maloney W, Clohisy J, Burnett RS, Grosso L, Gatchel SK, Gage BF. Voora D, et al. Thromb Haemost. 2005 Apr;93(4):700-5. doi: 10.1160/TH04-08-0542. Thromb Haemost. 2005. PMID: 15841315

9

Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.

Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Birman-Deych E, et al. Stroke. 2006 Apr;37(4):1070-4. doi: 10.1161/01.STR.0000208294.46968.a4. Epub 2006 Mar 9. Stroke. 2006. PMID: 16528001

10

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

Millican EA, Lenzini PA, Milligan PE, Grosso L, Eby C, Deych E, Grice G, Clohisy JC, Barrack RL, Burnett RS, Voora D, Gatchel S, Tiemeier A, Gage BF. Millican EA, et al. Blood. 2007 Sep 1;110(5):1511-5. doi: 10.1182/blood-2007-01-069609. Epub 2007 Mar 26. Blood. 2007. PMID: 17387222 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters